QUALITY OF LIFE IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA TREATED WITH THE BCMA-TARGETED CAR T CELL THERAPY IDECABTAGENE VICLEUCEL (IDE-CEL; BB2121): RESULTS FROM THE KARMMA TRIAL

EHA Library, Julia Braverman, 293491

BENEFICIAL EFFECT ON OVERALL SURVIVAL OF EARLY SALVAGE TREATMENT WITH SECOND-GENERATION NOVEL AGENTS AT BIOCHEMICAL RELAPSE: A REAL-WORLD SINGLE CENTER EXPERIENCE

EHA Library, Uros Markovic, 293492

REAL-WORLD OUTCOMES OF BELANTAMAB MAFODITIN TREATMENT FOR PATIENTS WITH RELAPSED/REFRACTORY MYELOMA VIA GSK EXPANDED ACCESS PROGRAM.

EHA Library, Tamir Shragai, 293493

DIFFUSION WEIGHTED WHOLE BODY MRI FOR EVALUATION OF RESPONSE AFTER ASCT IN MULTIPLE MYELOMA

EHA Library, Gregorio Barilà, 293494

LENALIDOMIDE AND LOW-DOSE DEXAMETHASONE (RD) AS FIRST LINE TREATMENT OF NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE TO STEM CELL TRANSPLANTATION: REAL LIFE ITALIAN EXPERIENCE

EHA Library, ALESSANDRA POMPA, 293495

CLINICAL OUTCOMES AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) AMONG RANDOMIZED CLINICAL TRIAL (RCT)-ELIGIBLE AND RCT-INELIGIBLE PATIENTS: RESULTS FROM THE CONNECT® MM REGISTRY

EHA Library, Lynne Wagner, 293496

DREAMM-2: SINGLE-AGENT BELANTAMAB MAFODOTIN (GSK2857916) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) AND RENAL IMPAIRMENT

EHA Library, Hans Lee, 293497

EFFICACY AND TOXICITY OF AUTOLOGOUS BLOOD STEM CELL TRANSPLANTATION IN ELDERLY MYELOMA PATIENTS

EHA Library, Sejla Hujic, 293498

TREATMENT PATTERNS OF LENALIDOMIDE DELIVERY AND OUTCOMES IN MULTIPLE MYELOMA PATIENTS IN REAL-WORLD SETTINGS: A MULTI-CENTER RETROSPECTIVE STUDY

EHA Library, Wolfgang Willenbacher, 293499

ISATUXIMAB SHORT-DURATION FIXED-VOLUME INFUSION COMBINATION THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: FINAL RESULTS OF A PHASE 1B FEASIBILITY/SAFETY STUDY

EHA Library, Saad Z. Usmani, 293500

RESPONSE TO CARFILZOMIB REGIMENS AMONG PATIENTS WITH EARLY OR LATE RELAPSE FOLLOWING PRIOR MULTIPLE MYELOMA THERAPY: A SUBGROUP ANALYSIS FROM A PROSPECTIVE OBSERVATIONAL STUDY ACROSS EUROPE AND ISRAEL

EHA Library, Evangelos Terpos, 293501

PROGNOSTIC IMPACT OF CYTOGENETIC EVOLUTION AND ACQUISITION OF DEL(17P) IN MULTIPLE MYELOMA

EHA Library, Aleksander Salomon-Perzyński, 293502

THE PROGNOSTIC IMPACT OF 1Q21 GAIN IN NEWLY DIAGNOSED MULTIPLE MYELOMA. A MULTICENTER STUDY.

EHA Library, Rafael Rios-Tamayo, 293503

REAL WORLD EXPERIENCE OF SALVAGE 2ND AUTOGRAFT FOR RELAPSED MYELOMA: TIME TO PROGRESSION AFTER 1ST AUTOGRAFT AND CONSOLIDATION/MAINTENANCE IMPROVE PROGRESSION FREE SURVIVAL

EHA Library, Huw Richards, 293505

POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE AFTER 1 PRIOR LINE OF THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL IMPAIRMENT: OPTIMISMM SUBANALYSIS

EHA Library, Fredrik Schjesvold, 293506

DREAMM-2: ASSESSING EFFICACY VIA INDIRECT COMPARISON OF SINGLE-AGENT BELANTAMAB MAFODOTIN VERSUS SELINEXOR PLUS DEXAMETHASONE COMBINATION IN ANTI-CD38 EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Rakesh Popat, 293507

ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS WITH 1Q21 GAIN: INSIGHTS FROM PHASE 1 AND PHASE 3 STUDIES

EHA Library, PAUL RICHARDSON, 293508

THROMBOTIC MICROANGIOPATHY IN MYELOMA PATIENTS TREATED WITH FRONTLINE CARFILZOMIB ON THE PHASE 2 CARDAMON TRIAL

EHA Library, Marquita Camilleri, 293509

ORTHOTOPIC HEART TRANSPLANT FACILITATED AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LIGHT-CHAIN AMYLOIDOSIS: LONG-TERM OUTCOMES

EHA Library, Rammurti Kamble, 293510

ASSESSMENT OF DISEASE BURDEN IN TERMS OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MULTIPLE MYELOMA NOT ELIGIBLE FOR ASCT IN SPAIN: UPDATE OF THE QOLMMBUS STUDY

EHA Library, Javier DE LA RUBIA, 293511

AMINO ACID-BASED FLUCICLOVINE PET/CT DETECTION OF MULTIPLE MYELOMA

EHA Library, Jakob Nordberg Nørgaard, 293512

POMALIDOMIDE-BASED TREATMENT IN RELAPSED REFRACTORY MULTIPLE MYELOMA: ANALYSIS BY FIRST-LINE MELPHALAN THERAPY IN A EUROPEAN POST-AUTHORIZATION SAFETY STUDY

EHA Library, Niels Abildgaard, 293513

A NATIONWIDE, POPULATION-BASED REGISTER OF SYSTEMIC AL AMYLOIDOSIS PATIENTS IN THE NETHERLANDS; PRELIMINARY RESULTS OF 205 PATIENTS DIAGNOSED IN 2017 AND 2018

EHA Library, Mirian Brink, 293514

REAL-LIFE TREATMENT OUTCOME OF FIRST-LINE REGIMEN FOR NON-TRANSPLANT ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Yasutaka Kakinoki, 293515

IBRUTINIB TREATMENT FOR PEDIATRIC CHRONIC GRAFT VERSUS HOST DISEASE: A PROSPECTIVE PHASE 1/2 STUDY

EHA Library, Marco Zecca, 293873

FEATURES OF EPSTEIN-BARR VIRUS AND CYTOMEGALOVIRUS REACTIVATION AFTER HAPLOIDENTICAL DONOR HEMATOPOIETIC CELL TRANSPLANTATION IN PATIENTS WITH ACUTE LEUKEMIAS

EHA Library, Yuhua Ru, 293874

RELAPSE HAS NOT DECREASED OVER TIME IN PATIENTS WITH HIGH-RISK MYELODISPLASTIC SYNDROME UNDERGOING AN ALLOGENEIC HEMOPOIETIC STEM CELL TRANSPLANTATION.

EHA Library, Alessia Di Giovanni, 293875

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR ADULT PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA: A NORDIC RETROSPECTIVE STUDY

EHA Library, Eileen Wedge, 293876

KYNURENINE METABOLITES AND INTERLEUKIN 18 IN FIBROSING CHRONIC GRAFT-VERSUS-HOST DISEASE

EHA Library, Thomas Luft, 293877

A PRO-OXIDANT COMBINATION OF RESVERATROL AND COPPER TO REDUCE POST-TRANSPLANT TOXICITY IN PATIENTS WITH MULTIPLE MYELOMA RECEIVING HIGH DOSE MELPHALAN: RESULTS OF AN EXPLORATORY STUDY (RESCU 001).

EHA Library, Anshul Agarwal, 293878

THE NATURAL HISTORY OF EBV REPLICATION, VIRAL LOAD DYNAMICS AND EBV-RELATED DISEASE FOLLOWING T CELL-DEPLETED ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)

EHA Library, Maria A. V. Marzolini, 293879

WILMS' TUMOR GENE 1 EXPRESSION IS AN INDEPENDENT PROGNOSTIC INDICATOR FOR PEDIATRIC ACUTE MYELOID LEUKEMIA FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Dao-Xing Deng, 293880

POOR GRAFT FUNCTION AFTER UNMANIPULATED HAPLOIDENTICAL SCT WITH POST-TRANSPLANT HIGH DOSE CYCLOPHOSPHAMIDE.

EHA Library, Ignacio Gómez-Centurión, 293881

AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN MULTIPLE MYELOMA (MM): DOES THE DOSE OF MELPHALAN MATTER? A SINGLE CENTER ANALYSIS ON 313 CONSECUTIVE PATIENTS.

EHA Library, Annamaria Brioli, 293882

STAGE IV INTESTINAL ACUTE GRAFT VERSUS HOST DISEASE: EXPERIENCE AFTER 1428 ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONS

EHA Library, Felipe Peña Muñoz, 293883

HIGH PLASMA VITAMIN E LEVELS ARE ASSOCIATED WITH DECREASED ACUTE GRAFT-VERSUS-HOST DISEASE AFTER MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Lars Klingen Gjærde, 293884

INCIDENCE, RISK FACTORS AND OUTCOMES OF DIFFUSE ALVEOLAR HAEMORRHAGE AFTER HAPLOIDENTICAL ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Jin Wu, 293885

PROGNOSTIC IMPACT ON THE DOSAGE OF METHOTREXATE COMBINED WITH TACROLIMUS FOR GRAFT-VERSUS HOST DISEASE PROPHYLAXIS AFTER CORD BLOOD TRANSPLANTATION

EHA Library, Miwa Adachi, 293886

BENDA-BEAM HIGH-DOSE THERAPY PRIOR TO AUTO-SCT IS EFFECTIVE IN RESISTANT/RELAPSED DLBCL: FINAL RESULTS FROM A PHASE II MULTI-INSITITUTIONAL STUDY

EHA Library, Alessandro Isidori, 293887

TWO YEAR FOLLOW UP OF ACUTE COMPLETE SPINAL CORD INJURY PATIENTS RECEIVING AUTOLOGOUS BONE MARROW-DERIVED MONONUCLEAR STEM CELL THERAPY

EHA Library, Renu Rani, 293888

FEASIBILITY AND EFFICACY OF HAPLOIDENTICAL STEM CELL TRANSPLANTATION IN ADVANCED STAGE MYCOSIS FUNGOIDES AND SÉZARY SYNDROME: A REPORT OF FIVE CONSECUTIVE CASES

EHA Library, Fabio Serpenti, 293889

EFFICACY OF HAPLOIDENTICAL ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA WITH MODIFIED FC PRECONDITIONING ：A REPORT OF 35 CASES

EHA Library, Ma Liangming, 293890

CLINICAL RELEVANCE OF MYC/BCL2, CELL OF ORIGIN AND CONDITIONING REGIMEN IN PATIENTS WITH RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH ALLOGENEIC STEM CELL TRANSPLANTATION (ALLOSCT).

EHA Library, Issa Khouri, 293891

NEIHULIZUMAB (ABGN-168H) IN PATIENTS WITH STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST-DIEASE (SR-AGVHD): PRELIMINARY RESULTS OF A PHASE I STUDY

EHA Library, Sameem Abedin, 293892

STAND-BY ANTIBIOTIC TREATMENT VERSUS ANTIBIOTIC PROPHYLAXIS DURING ALLOGENEIC STEM CELL TRANSPLANTATION IS SAFE AND FEASIBLE: A RETROSPECTIVE MONOCENTER ANALYSIS

EHA Library, Rosa Toenges, 293893

PREEMPTIVE ADMINISTRATION OF JAK1/2 INHIBITOR RUXOLITINIB RAPIDLY AMELIORATE GVHD AFTER ALLO-HEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTI-CENTER RETROSPECTIVE STUDY

EHA Library, Ting Yang, 293894

INVASIVE FUNGAL DISEASE CHARACTERISTICS IN ADULT HEMATOLOGICAL MALIGNANCY PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RESULTS OF NATION-WIDE CROSS-SECTIONAL 2012-2014

EHA Library, Patrycja Mensah-Glanowska, 293895

ALEMTUZUMAB FOR IN VIVO T-CELL DEPLETION IN UNRELATED DONOR ALLOGENEIC STEM CELL TRANSPLANTATION: DECREASING THE DOSE FROM 60 MG TO 30 MG RESULTS IN EQUIVALENT OUTCOMES

EHA Library, Sara Lozano, 293896

POST-TRANSPLANT CYCLOPHOSPHAMIDE AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN HLA MATCHED SIBLING TRANSPLANT IN ACUTE LEUKAEMIA

EHA Library, Alaa Elshamy, 293897

RITUXIMAB FOR THE PREVENTION OF ANEMIA POST ABO MAJOR INCOMPATIBLE ALLOGENEIC STEM CELL TRANSPLANTATION.

EHA Library, Maria Chiara Finazzi, 293898

COMPARISON OF IMMUNOSUPPRESSIVE AGENT REDUCTION AND DONOR LYMPHOCYTE INFUSION IN CORRECTION OF A MIXED CHIMERISM POST-TRANSPLANTATION IN PATIENT WITH THALASSEMIA

EHA Library, Jianyun Liao, 293899

CO-TRANSPLANTATION OF MESENCHYMAL STEM CELLS IMPROVES THE PROGNOSIS OF ALLO-HSCT IN THE TREATMENT OF HEMATOLOGIC MALIGNANCIES: A SINGLE-CENTER RETROSPECTIVE STUDY OF 175 PATIENTS

EHA Library, Ting Yang, 293900

EFFICACY OF DONOR AND ‘THIRD PARTY' DERIVED EBV-SPECIFIC CYTOTOXIC T CELLS FOR TREATMENT OF RITUXIMAB-REFRACTORY EBV-PTLD AFTER ALLO-HSCT IN PEDIATRIC PATIENTS

EHA Library, Xiaodong Wang, 293901

ANALYSIS OF IMPROVED RESULTS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION PROMOTED BY KIR MISMATCHING, DONOR KIR3DS1-POSITIVE OR KIR2DS3-NEGATIVE THROUGH A SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Ting Yang, 293902

AUTOLOGOUS STEM CELL TRANSPLANTATION IN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: A RETROSPECTIVE ANALYSIS FROM THE LYMPHOMA WORKING PARTY OF THE EBMT

EHA Library, Toby Eyre, 293903

LOWER NRM AND BETTER GRFS WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE (PTCY) COMPARED WITH ANTITHYMOCITE GLOBULIN (ATG) IN UNRELATED HEMATOPIETIC TRANSPLANTATION (URD). A SINGLE CENTER EXPERIENCE.

EHA Library, Mariano Berro, 293904

THE IMPORTANCE OF THE REGIONAL PUBLIC CORD BLOOD BANK OF CRETE FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ACCESS OF THE CRETAN POPULATION

EHA Library, Emmanouil Stylianakis, 293905

CURCUMIN ALLEVIATES ORAL MUCOSITIS AND OTHER TOXICITIES ASSOCIATED WITH HIGH-DOSE MELPHALAN BY MODULATING PRO AND ANTI-INFLAMMATORY CYTOKINES

EHA Library, Kritika Katti, 293906

CARBAPENEMASE-PRODUCING KLEBSIELLA PNEUMONIAE INFECTIONS ARE ASSOCIATED WITH HIGH RATES OF ACUTE GRAFT-VERSUS-HOST DISEASE AND TREATMENT-RELATED MORTALITY

EHA Library, Eleni Gavriilaki, 293907

CRYOTHERAPY VS SUPERSATURATED CALCIUM PHOSPHATE RINSES IN MULTIPLE MYELOMA PATIENTS TREATED WITH HIGH-DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANT: A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL

EHA Library, Dorra Belloumi, 293908

NON-MYELOABLATIVE MATCHED STEM CELL TRANSPLANTATION WITH OPTIONAL REINFORCED STEM CELL INFUSION FOR HEMOGLOBINOPATHIES

EHA Library, Seung-Hwan Shin, 293909

PRETRANSPLANT HIGH FERRITINEMIA IS ASSOCIATED WITH HIGHER RISK OF EARLY DOCUMENTED INFECTIONS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Nour Ben Adejlil, 293910

ISAVUCONAZOLE IN ALLOGENEIC STEM CELL TRANSPLANTATION. A REAL-LIFE REPORT FROM THE SPANISH GROUP OF TRANSPLANT AND CELLULAR THERAPY (GETH).

EHA Library, Gillen Oarbeascoa, 293911

BEEAM CONDITIONING REGIMEN IS AN EFFICACIOUS AND ECONOMICAL ALTERNATIVE TO BEAM CHEMOTHERAPY

EHA Library, Logan Hahn, 293912

ANTIEMETIC PROPHYLAXIS WITH FOSAPREPITANT IN PEDIATRIC PATIENTS WITH HEMATOLOGIC MALIGNANCIES UNDERGOING AUTOLOGOUS HSCT

EHA Library, Michaela Döring, 293913

UTILITY OF CD4+/CD8+ RATIO IN BRONCHOALVEOLAR LAVAGE FLUID IN DETECTING THE CAUSE OF ACUTE LUNG INJURY IN THE PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Hajime Senjo, 293914

THE PROGNOSTIC VALUE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR–LIGAND MISMATCH IN DONOR VERSUS RECIPIENT DIRECTION ON THE OUTCOMES OF HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION.

EHA Library, Zoya Konova, 293915

CIPROFLOXACIN PROPHYLAXIS IN HEMATOPOIETIC STEM CELL TRANSPLANT: IMPACT ON MORTALITY AND MICROBIOLOGICAL RESISTANCE

EHA Library, Inés Paganini, 293916

FEASIBILITY AND SAFETY OF NON-CRYOPRESERVED PERIPHERAL BLOOD STEM CELLS AUTOLOGOUS TRANSPLANTATION IN MULTIPLE MYELOMA: BICENTRIC STUDY.

EHA Library, Selim Jennane, 293917

FEASIBILITY OF THE EBMT RISK SCORE FOR ASSESSING TRANSPLANT RELATED MORTALITY FOR PATIENTS WITH ACUTE LEUKEMIA TRANSPLANTED AT NATIONAL RESEARCH CENTER FOR HEMATOLOGY, RUSSIA (2009-2019)

EHA Library, Feruza Omarova, 293918

BLOODSTREAM INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS: A FOUR YEARS SURVEY

EHA Library, Khouloud TOUIHRI, 293919

ASSOCIATION BETWEEN THE KINETICS OF CYTOMEGALOVIRUS REACTIVATION IN TERMS OF THE AREA UNDER THE CURVE OF CYTOMEGALOVIRUS ANTIGENEMIA AND NRM AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Junko Takeshita, 293920

OUTCOME OF FLUDARABINE-BUSULFAN-ANTI THYMOCYTE GLOBULIN (FLU-BU-ATG) CONDITIONING REGIMEN FOR ALLOGENEIC HEMATOPIETIC STEM CELL TRANSPLANTATION

EHA Library, Ahmed Askar, 293921

PRESENTATION AND MANAGEMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE IN REAL-WORLD CLINICAL PRACTICE: A MEDICAL CHART AUDIT

EHA Library, Amandeep Salhotra, 293922

10-YEAR OVERALL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION (RESULTS OF AN ONE-CENTER STUDY)

EHA Library, Maxim Solovev, 293923

CLINICAL OUTCOMES OF POST LYMPHOPROLIFERATIVE DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – SIX-YEAR PERIOD CENTER EXPERIENCE

EHA Library, Carolina Pavao, 293924

5' ECTONUCLEOTIDASE (CD73) MAY PREDICT THE OCCURRENCE OF CGVHD AND GRADE OF AGVHD IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Walaa Elsalakawy, 293925

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH UNFAVORABLE CD34+ CELLS YIELD IN PATIENTS WITH NON- HODGKIN LYMPHOMA

EHA Library, Weiping Liu, 293926

GEMCITABINE AND DOCETAXEL PROTOCOL AS INTENT TO AUTOLOGOUS BONE MARROW TRANSPLANTATION IN PATIENTS WITH REFRACTORY AND RELAPSED NON HODGKIN LYMPHOMA: SINGLE INSTITUTIONAL PROSPECTIVE PHASE II STUDY

EHA Library, Doaa Hassan, 293927

AN INSPIRING RESULT OF UMBILICAL CORD BLOOD TRANSPLANTATION AFTER ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR THERAPY IN CHILDREN RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Fang Liu, 293928

TISSUE-SCALE SPATIAL ANALYSIS OF HEMATOPOIETIC STEM CELL NICHES IN THE FETAL LIVER MICROENVIRONMENT

EHA Library, Cesar Nombela Arrieta, 293929

BONE MARROW MICROENVIRONMENT IN ΒETA-THALASSEMIA: UNRAVELING THE IMPACT OF DEFECTIVE MEGAKARYOCYTES ON HEMATOPOIETIC STEM CELL FUNCTION

EHA Library, Annamaria Aprile, 293930

MITOCHONDRIAL ELECTRON TRANSPORT CHAIN COMPLEX II DYSFUNCTION DRIVES PREMATURE AGING OF HEMATOPOIETIC STEM CELLS

EHA Library, Kaito Harada, 293931

ASSESSMENT OF MUTATION BURDEN IN HEMATOPOIETIC STEM CELL CLONES AS A RESULT OF AGING AND INFLAMMATORY STRESS

EHA Library, Megan Druce, 293932

SINGLE-CELL RNASEQ OF HEMATOPOIETIC PROGENITORS REVEALS ALTERED GENE REGULATORY NETWORKS IN HUMAN AGING

EHA Library, Marina Ainciburu, 293933

HIGH ENERGY DEMAND UPREGULATES GLYCOLYTIC ATP PRODUCTION IN HEMATOPOIETIC STEM CELLS VIA AMPK / PFKFB3 AXIS

EHA Library, Shintaro Watanuki, 293934

THE B-CATENIN-TCF/LEF TRANSCRIPTION COMPLEX SUPPRESSES HEMATOPOIETIC STEM CELL SELF-RENEWAL AND IS DISPENSABLE FOR LEUKEMIA DEVELOPMENT

EHA Library, Petr Daněk, 293935

MITOCHONDRIAL REPROGRAMMING OF HUMAN ERYTHROID PROGENITORS CONTROLS TERMINAL DIFFERENTIATION

EHA Library, Pedro Gonzalez-Menendez, 293937

HEMATOPOIETIC STEM CELLS SUSTAIN MATURE BLOOD CELL PRODUCTION DURING STRESS HEMATOPOIESIS ON THE EXPENSE OF SELF-RENEWAL

EHA Library, Ana-Matea Mikecin Drazic, 293940

EXPRESSION OF ERYTHROPOIETIN RECEPTOR (EPO-R) IS REQUIRED FOR PROPER OSTEOBLAST FUNCTION

EHA Library, Martina Rauner, 293941

TAILORING FOR DEVELOPMENT: A TRANSIENT WAVE OF HSC-DERIVED INNATE LYMPHOID PROGENITORS COLONIZES AND SHAPES THE MOUSE EMBRYO THYMIC ARCHITECTURE.

EHA Library, Ramy ELSAID, 293942

CK2 HAS A KEY ROLE IN HEMATOPOIESIS FROM HSC TO MORE DIFFERENTIATED CELLS.

EHA Library, Laura Quotti Tubi, 293943

NOVEL ROLE(S) FOR IRF5 IN CONTROLLING MYELOPOIESIS AND ERYTHROPOIESIS

EHA Library, Lionel Blanc, 293945

OPTIMISATION OF LEUKEMIC AND HEMATOPOIETIC 3D MODELS FOR COMPARATIVE BIO-PHYSICAL ANALYSIS AND THERAPEUTIC SCREENING

EHA Library, Jenna James, 293946

IRS2 IS REQUIRED TO EFFICIENT ERYTHROID AND MEGAKARYOCYTIC DIFFERENTIATION IN MURINE MODEL

EHA Library, Bruna Alves Fenerich, 293947

DEVELOPMENT OF CULTURE SYSTEM FOR HUMAN HEMATOPOIETIC STEM CELLS WITHOUT CYTOKINES

EHA Library, Masatoshi Sakurai, 293948

ANTIOXIDANTS PROTECT HEMATOPOIETIC STEM/PROGENITOR CELLS AGAINST OXIDATIVE STRESS AND LOSS OF STEMNESS PROPERTIES DURING EX VIVO MANIPULATION IN CELL AND GENE THERAPY PROTOCOLS

EHA Library, Elia Henry, 293949

STEM CELL BASED HETEROGENEITY OF INTERFERON SIGNALING DURING HEMATOPOIETIC DEVELOPMENT

EHA Library, Paula Werner, 293950

CHRONIC PSYCHOLOGICAL STRESS DIFFERENTIALLY ALTERS BONE MARROW AND SPLEEN MICROENVIRONMENT TOWARD ENHANCED ERYTHROPOIESIS

EHA Library, Sanja Momčilović, 293951

KINETICS AND COMPOSITION OF HEMATOPOIETIC STEM/PROGENITORS MOBILIZED CELLS UPON G-CSF AND PLERIXAFOR ADMINISTRATION IN TRANSPLANT DONOR OR PATIENTS UNDERGOING AUTOLOGOUS GENE THERAPY.

EHA Library, Luca Basso-Ricci, 293952